ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study.
ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study. Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF. In addition, Pittsburg Sleep Quality Index will be applied to all cases. In addition, clinical features of HF from the current file of the cases (NYHA, comorbid conditions, comorbid diseases, blood pressure, heart rate, last drugs used, latest biochemistry (BNP/NTproBNP if available), hematology test results, most recent ECG , most recent echocardiography, coronary angiography report, if available) will be recorded. No additional examination/procedure will be performed for the study, only the data of the examinations requested by the clinician in routine clinical practice will be entered. A total of 500 patients from 10 centers will be included in this study over a six-month period.
Study Type
OBSERVATIONAL
Enrollment
500
Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF (presented in the appendix to this protocol). In addition, Pittsburg Sleep Quality Index will be applied to all cases.
Ankara City Hospital
Ankara, Turkey (Türkiye)
Akdeniz University Medical Faculty
Antalya, Turkey (Türkiye)
Eskişehir Osmangazi University Medical Faculty
Eskişehir, Turkey (Türkiye)
General Status of the patients
At the end of the six-month recruitment period, demographic, symptoms, clinical follow-up status, disease information, treatment compliance, and awareness assessment will be performed on all included patients.
Time frame: 6 months
HF Risk Factors
Time frame: 6 Months
HF Percutaneous Intervention History & Operation History
Time frame: 6 Months
Medications Used for HF
Time frame: 6 Months
HF Comorbidities
Time frame: 6 Months
HF ECHO Results
Time frame: 6 Months
HF Laboratory Results
Time frame: 6 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Başkent University Istanbul Health Practice and Research Center Hospital
Istanbul, Turkey (Türkiye)
Dr. Siyami Ersek Chest Cardiac and Vascular Surgery T&R Hospital
Istanbul, Turkey (Türkiye)
Istanbul University - Cerrahpaşa, Cardiology Institute
Istanbul, Turkey (Türkiye)
Dokuz Eylül University Medical Faculty
Izmir, Turkey (Türkiye)
Ege University Medical Faculty
Izmir, Turkey (Türkiye)
Tepecik Training and Research Hospital
Izmir, Turkey (Türkiye)
Mersin University Medical Faculty
Mersin, Turkey (Türkiye)